Materials and general procedures
Seven PDUFA dates on FDAs January agenda Decisions include Ozempic for CKD, a non-opioid painkiller, AZ-Daiichis TROP2 ADC, and an allogeneic T cell therapy The already strong growth of semaglutide may get another boost with Novo Nordisk expecting a decision this month on use of Ozempic to treat chronic kidney disease in Type II diabetes patients
For powder (unreconstituted) tirzepatide, storage requirements are less strict but still important
Obesity and insulin resistance share connections
Dosage : As prescribed by the Doctor
7 min read Medi-Cal Cuts Create Problems for Silicon Valley Immigrants Budget cuts to Medi-Cal are unraveling healthcare access for Silicon Valley's immigrant communities, leading to service delays, medication reductions, and fears of exposure